炎症性肠病患者急性心肌梗死与心力衰竭风险增加
基于美国明尼苏达州奥姆斯特德县1980至2010年人群队列,纳入736例炎症性肠病患者并按年龄、性别和诊断日期匹配1472名无炎症性肠病对照。校正传统心血管危险因素后,炎症性肠病与急性心肌梗死(aHR 2.82,95%CI 1.98-4.04)和心力衰竭(aHR 2.03,95%CI 1.36-3.03)风险升高独立相关。
要点
- 炎症性肠病患者急性心肌梗死风险升高(aHR 2.82,95%CI 1.98-4.04)。
- 炎症性肠病患者心力衰竭风险升高(aHR 2.03,95%CI 1.36-3.03)。
- 使用全身性糖皮质激素者急性心肌梗死和心力衰竭风险均升高。
核心结论
- 基于人群的队列研究发现,尽管炎症性肠病患者传统急性心肌梗死和心力衰竭危险因素患病率较低,但其发生这些心血管疾病的风险增加。
研究设计与样本
- 研究为基于人群的队列研究,纳入1980年至2010年在美国明尼苏达州奥姆斯特德县诊断为炎症性肠病的患者736例。
- 每例患者随机选取2名无炎症性肠病个体作为对照(共1472名),按年龄、性别和疾病诊断索引日期匹配。
- 主要结局为急性心肌梗死和心力衰竭,采用Cox比例风险分析估计风险。
主要发现
- 校正传统心血管疾病危险因素后,炎症性肠病独立与急性心肌梗死风险升高相关(aHR 2.82,95%CI 1.98-4.04)。
- 校正传统心血管疾病危险因素后,炎症性肠病独立与心力衰竭风险升高相关(aHR 2.03,95%CI 1.36-3.03)。
- 急性心肌梗死相对风险在克罗恩病患者(aHR 2.89,95%CI 1.65-5.13)和溃疡性结肠炎患者(aHR 2.70,95%CI 1.69-4.35)中均显著升高。
- 急性心肌梗死相对风险在使用全身性糖皮质激素者中升高(aHR 5.08,95%CI 3.00-8.81),未使用者中也升高(aHR 1.79,95%CI 1.08-2.98)。
- 心力衰竭相对风险在溃疡性结肠炎患者中显著升高(aHR 2.06,95%CI 1.18-3.65),克罗恩病患者中未显著升高;使用全身性糖皮质激素者心力衰竭风险升高(aHR 2.51,95%CI 1.93-4.57),未使用者中未升高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: There are conflicting data as to whether inflammatory bowel diseases (IBDs) increase risk for cardiovascular disease. We sought to examine the risk of acute myocardial infarction (AMI) and heart failure in patients with IBD. METHODS: We identified patients diagnosed with IBD in Olmsted County, Minnesota, from 1980 through 2010 (n = 736). For each patient, 2 individuals without IBD (controls, n = 1472) were randomly selected, matched for age, sex, and index date of disease diagnosis. Primary outcomes were AMI and heart failure. Cox proportional hazards analysis was used to estimate the risk of AMI and heart failure. RESULTS: After adjustments for traditional cardiovascular disease risk factors, IBD associated independently with increased risk of AMI (adjusted hazard ratio [aHR], 2.82; 95% CI, 1.98-4.04) and heart failure (aHR, 2.03; 95% CI, 1.36-3.03). The relative risk of AMI was significantly increased in patients with Crohn's disease (aHR vs controls, 2.89; 95% CI, 1.65-5.13) or ulcerative colitis (aHR vs controls, 2.70; 1.69-4.35). The relative risk of AMI was increased among users of systemic corticosteroids (aHR vs controls, 5.08; 95% CI, 3.00-8.81) and nonusers (aHR vs controls, 1.79; 95% CI, 1.08-2.98). The relative risk of heart failure was significantly increased among patients with ulcerative colitis (aHR, 2.06; 95% CI, 1.18-3.65), but not Crohn's disease. The relative risk of heart failure was increased among users of systemic corticosteroids (aHR, 2.51; 95% CI, 1.93-4.57), but not nonusers. CONCLUSIONS: In a population-based cohort study, we found that despite a lower prevalence of traditional risk factors for AMI and heart failure, patients with IBD are at increased risk for these cardiovascular disorders.
引用
- Aniwan S, Pardi DS, Tremaine WJ, et al. Increased Risk of Acute Myocardial Infarction and Heart Failure in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2018. PMID: 29702298. doi:10.1016/j.cgh.2018.04.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。